TELEBPMET: Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants
Study Details
Study Description
Brief Summary
The purpose of this study is to assess whether, in patients at high cardiovascular risk (hypertension with metabolic syndrome), long-term (1-year) blood pressure control is most effective when based on home blood pressure telemonitoring and on the feedback to the patient by the doctor between visits, or when based only on blood pressure determination during quarterly office visits.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Home blood pressure telemonitoring Patients regularly monitoring their blood pressure at home with an electronic validated upper arm device, transmitting blood pressure values at monthly intervals to the doctors office through the Internet. |
|
Conventional blood pressure measurement Blood pressure measured only in the doctor's office during quarterly visits, without regular home blood pressure monitoring. |
Outcome Measures
Primary Outcome Measures
- Percentage of subjects with average day-time ambulatory blood pressure <135/85 mmHg [6 months]
- Percentage of subjects with average day-time ambulatory blood pressure <135/85 mmHg [12 months]
Secondary Outcome Measures
- Psychological determinats of therapeutic adherence [6 months]
- Percentage of subjects with office blood pressure <140/90 mmHg [6 months]
- Changes in home blood pressure [6 months]
- Number of additional medical visits [6 months]
- Direct costs of intervention [6 months]
- Number of antihypertensive drugs [6 months]
- Level of cardiovascular risk by ESC Heart Score and Framingham [6 months]
- Target organ damage and outcomes [6 months]
- Percentage of patients with metabolic syndrome [6 months]
- Psychological determinats of therapeutic adherence [12 months]
- Percentage of subjects with office blood pressure <140/90 mmHg [12 months]
- Changes in home blood pressure [12 months]
- Number of additional medical visits [12 months]
- Direct costs of intervention [12 months]
- Number of antihypertensive drugs [12 months]
- Level of cardiovascular risk by ESC Heart Score and Framingham [12 months]
- Target organ damage and outcomes [12 months]
- Percentage of patients with metabolic syndrome [12 months]
- Percentage of subjects with home blood pressure <135/85 mmHg [6 months]
- Percentage of subjects with home blood pressure <135/85 mmHg [12 months]
- Changes in 24h blood pressure [6 months]
- Changes in 24h blood pressure [12 months]
- Changes in office blood pressure [6 months]
- Changes in office blood pressure [12 months]
- Adherence to treatment [6 months]
- Adherence to treatment [12 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Treated or untreated uncontrolled essential arterial hypertension (office systolic blood pressure >140 or diastolic >90 mmHg + day-time systolic blood pressure >135 or day-time diastolic blood pressure >85 mmHg)
-
Metabolic syndrome (ATP III criteria)
Exclusion Criteria:
-
Secondary arterial hypertension
-
Severe liver or kidney disease
-
Immunological disease
-
Cardiac arrhythmias
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Fondazione Maugeri | Lumezzane | Brescia | Italy | 25066 |
2 | Ospedale San Felice a Cancello | San Felice a Cancello | Caserta | Italy | 81027 |
3 | Ospedale di Broni | Broni | Pavia | Italy | 27043 |
4 | Policlinico Universitario | Bari | Italy | 70124 | |
5 | Spedali Civili | Brescia | Italy | 25123 | |
6 | Istituto Auxologico Italiano | Milano | Italy | 20149 | |
7 | Policlinico Universitario | Padova | Italy | 35128 | |
8 | Fondazione Maugeri | Pavia | Italy | 27100 | |
9 | Ospedale Santa Chiara | Pisa | Italy | 56100 | |
10 | Ospedale Fatebenefratelli | Roma | Italy | 00186 | |
11 | Casa di Cura Tortorella | Salerno | Italy | 84122 | |
12 | Ospedale di Circolo | Varese | Italy | 21100 |
Sponsors and Collaborators
- Italian Institute of Telemedicine
- Bracco Corporate
- Istituto Auxologico Italiano
Investigators
- Principal Investigator: Gianfranco Parati, MD, Istituto Auxologico Italiano
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- TELEBPMET